SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Guggenheim Raises Pfizer Price Target to $33 From $31

Guggenheim adjusted its price target on Pfizer to $33 from $31.

PFE

Related stories